Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol F9 contributors: mct/npt - updated : 02-06-2013
HGNC name coagulation factor IX
HGNC id 3551
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver   highly
cell lineage
cell lines
fluid/secretion
  • plasma
  • at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • N terminus GLA domain, that with C2 domain of factor VIIIa are involved in phospholipid binding and are required for the activation of factor X (Soeda 2009)
  • an EGF2 domain (contacts between EGF2 and the protease domain of FIXa are crucial for FIXa enzymatic activity and for the assembly of the FX-activating complex) (Fribourg 2006)
  • two cysteine-rich domains highly homologous to EGF,
  • a C terminal catalytic domain
  • conjugated GlycoP
    mono polymer aggregate
    isoforms Precursor . zymogen
    HOMOLOGY
    Homologene
    FAMILY
  • peptidase S1 family
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION extracellular
        plasma membrane
        intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    basic FUNCTION
  • vitamin K-dependent, serine protease, activator of FX, through interactions with Ca2+, membrane phospholipids end FVIII
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS coagulation/hemostasis
    PATHWAY
    metabolism
    signaling
    a component
  • plasma thromboplastic component
  • heterodimer of a light chain and a heavy chain, disulfide-linked
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • expression of F9 is crucially dependent on ONECUT factors (ONECUT1, ONECUT2)
  • hydrophobic helical stack between the GLA and EGF1 domains of F9 is predicted to be primary interacting region with the A3-C2 domain interface of F8
  • cell & other
    REGULATION
    activated by FXIa which excises the activation peptide and produces a molecule with a heavy and a light chain bound by disulfide bond(s)
    ASSOCIATED DISORDERS
    corresponding disease(s) F9D
    related resource Haemophilia B Mutation Database
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    is a common risk factor for deep vein thrombosis (van Hylckama 2000)
    Susceptibility for deep vein thrombosis
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS